BRPI0820779A2 - Derivados de 4-amino-pirimidina - Google Patents

Derivados de 4-amino-pirimidina

Info

Publication number: BRPI0820779A2
Authority: BR; Brazil
Prior art keywords: amino; pyrimidine derivatives; pyrimidine; derivatives
Prior art date: 2007-12-21

Application number

BRPI0820779-8A

Other languages

English (en)

Inventor

Elena Carceller González

Eva Maria Medina Fuentes

Robert Soliva Soliva

Marina Virgili Bernadó

Josep Martí Via

Original Assignee

Palau Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-21

Filing date

2008-12-18

Publication date

2015-06-16

2008-12-18 Application filed by Palau Pharma Sa filed Critical Palau Pharma Sa

2015-06-16 Publication of BRPI0820779A2 publication Critical patent/BRPI0820779A2/pt

2020-02-04 Publication of BRPI0820779B1 publication Critical patent/BRPI0820779B1/pt

2021-05-25 Publication of BRPI0820779B8 publication Critical patent/BRPI0820779B8/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Immunology (AREA)
Pulmonology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Transplantation (AREA)
Otolaryngology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

BRPI0820779A 2007-12-21 2008-12-18 compostos derivados de 4-amino-pirimidina, composição farmacêutica, uso e processo para preparação dos referidos compostos BRPI0820779B8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP07382006		2007-12-21
US3153408P	2008-02-26	2008-02-26
PCT/EP2008/067950 WO2009080721A2 (en)	2007-12-21	2008-12-18	4 -aminopyrimidine derivatives as histamine h4 receptor antagonists

Publications (3)

Publication Number	Publication Date
BRPI0820779A2 true BRPI0820779A2 (pt)	2015-06-16
BRPI0820779B1 BRPI0820779B1 (pt)	2020-02-04
BRPI0820779B8 BRPI0820779B8 (pt)	2021-05-25

Family

ID=39473347

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0820779A BRPI0820779B8 (pt)	2007-12-21	2008-12-18	compostos derivados de 4-amino-pirimidina, composição farmacêutica, uso e processo para preparação dos referidos compostos

Country Status (24)

Country	Link
US (1)	US8431580B2 (pt)
EP (1)	EP2235012B1 (pt)
JP (1)	JP5498396B2 (pt)
KR (1)	KR101639819B1 (pt)
CN (1)	CN101903385B (pt)
AR (1)	AR069814A1 (pt)
AU (1)	AU2008341678B2 (pt)
BR (1)	BRPI0820779B8 (pt)
CA (1)	CA2709650C (pt)
CL (1)	CL2008003811A1 (pt)
CY (1)	CY1114427T1 (pt)
DK (1)	DK2235012T3 (pt)
ES (1)	ES2430210T3 (pt)
HR (1)	HRP20130918T1 (pt)
IL (1)	IL206413A (pt)
PE (1)	PE20091330A1 (pt)
PL (1)	PL2235012T3 (pt)
PT (1)	PT2235012E (pt)
RU (1)	RU2489430C2 (pt)
SI (1)	SI2235012T1 (pt)
TW (1)	TWI429440B (pt)
UA (1)	UA101963C2 (pt)
WO (1)	WO2009080721A2 (pt)
ZA (1)	ZA201005179B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102007026341A1 (de)	2007-06-06	2008-12-11	Merck Patent Gmbh	Benzoxazolonderivate
DE102007032507A1 (de)	2007-07-12	2009-04-02	Merck Patent Gmbh	Pyridazinonderivate
DE102007061963A1 (de)	2007-12-21	2009-06-25	Merck Patent Gmbh	Pyridazinonderivate
DE102008019907A1 (de)	2008-04-21	2009-10-22	Merck Patent Gmbh	Pyridazinonderivate
DE102008028905A1 (de)	2008-06-18	2009-12-24	Merck Patent Gmbh	3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate
US8586599B2 (en)	2008-12-22	2013-11-19	Merck Patent Gmbh	Polymorphic forms of 6-(1-methyl-1H-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2H-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof
EP2201982A1 (en) *	2008-12-24	2010-06-30	INSERM (Institut National de la Santé et de la Recherche Médicale)	Histamine H4 receptor antagonists for the treatment of vestibular disorders
PT2493895T (pt)	2009-10-29	2017-07-05	Vectura Ltd	Derivados de heteroarilo contendo n como inibidores de cinases jak3
AU2010334804B2 (en) *	2009-12-23	2015-04-02	Palau Pharma, S.L.U.	Aminoalkylpyrimidine derivatives as histamine H4 receptor antagonists
DK2858647T3 (en)	2012-06-08	2018-08-20	Sensorion	H4 RECEPTOR INHIBITORS FOR TINNITUS TREATMENT
TWI797176B (zh) *	2017-10-17	2023-04-01	西班牙商帕羅製藥有限公司	４-胺基嘧啶化合物之合成
GB201817047D0 (en)	2018-10-19	2018-12-05	Heptares Therapeutics Ltd	H4 antagonist compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2361869C2 (ru) *	2002-02-05	2009-07-20	ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи	Новые арил- и гетероарилпиперазины
EP1505064A1 (en) *	2003-08-05	2005-02-09	Bayer HealthCare AG	2-Aminopyrimidine derivatives
WO2005054239A1 (en) *	2003-12-05	2005-06-16	Bayer Healthcare Ag	2-aminopyrimidine derivatives
UA83101C2 (en) *	2003-12-15	2008-06-10	Алмирал Аг	2,6-bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists
DE602006020864D1 (de) *	2005-04-11	2011-05-05	Almirall Sa	2, 6-di-(hetero-)aryl-4-amido-pyrimidine als adenosin-rezeptor-antagonisten
JP2009507896A (ja) *	2005-09-13	2009-02-26	パラウ・フアルマ・ソシエダツド・アノニマ	ヒスタミンｈ４受容体活性の調節剤としての２−アミノピリミジン誘導体
WO2007084914A2 (en) *	2006-01-17	2007-07-26	Neurocrine Biosciences, Inc.	Phenoxy-substituted pyrimidines as adenosine receptor antagonists

2008
- 2008-12-18 WO PCT/EP2008/067950 patent/WO2009080721A2/en not_active Ceased
- 2008-12-18 UA UAA201007805A patent/UA101963C2/ru unknown
- 2008-12-18 US US12/809,371 patent/US8431580B2/en active Active
- 2008-12-18 BR BRPI0820779A patent/BRPI0820779B8/pt active IP Right Grant
- 2008-12-18 SI SI200831056T patent/SI2235012T1/sl unknown
- 2008-12-18 EP EP08865603.8A patent/EP2235012B1/en active Active
- 2008-12-18 DK DK08865603.8T patent/DK2235012T3/da active
- 2008-12-18 CA CA2709650A patent/CA2709650C/en active Active
- 2008-12-18 ES ES08865603T patent/ES2430210T3/es active Active
- 2008-12-18 JP JP2010538738A patent/JP5498396B2/ja active Active
- 2008-12-18 CN CN200880121970XA patent/CN101903385B/zh active Active
- 2008-12-18 KR KR1020107013477A patent/KR101639819B1/ko active Active
- 2008-12-18 PL PL08865603T patent/PL2235012T3/pl unknown
- 2008-12-18 AU AU2008341678A patent/AU2008341678B2/en active Active
- 2008-12-18 PT PT88656038T patent/PT2235012E/pt unknown
- 2008-12-18 TW TW097149462A patent/TWI429440B/zh active
- 2008-12-18 CL CL2008003811A patent/CL2008003811A1/es unknown
- 2008-12-18 AR ARP080105539A patent/AR069814A1/es unknown
- 2008-12-18 HR HRP20130918AT patent/HRP20130918T1/hr unknown
- 2008-12-18 RU RU2010130418/04A patent/RU2489430C2/ru active
- 2008-12-19 PE PE2008002160A patent/PE20091330A1/es active IP Right Grant
2010
- 2010-06-16 IL IL206413A patent/IL206413A/en active IP Right Grant
- 2010-07-20 ZA ZA2010/05179A patent/ZA201005179B/en unknown
2013
- 2013-09-10 CY CY20131100781T patent/CY1114427T1/el unknown

Also Published As

Publication number	Publication date
CA2709650A1 (en)	2009-07-02
WO2009080721A2 (en)	2009-07-02
KR101639819B1 (ko)	2016-07-14
ZA201005179B (en)	2012-03-28
PE20091330A1 (es)	2009-09-07
TWI429440B (zh)	2014-03-11
RU2010130418A (ru)	2012-01-27
DK2235012T3 (da)	2013-10-07
IL206413A (en)	2015-06-30
WO2009080721A3 (en)	2009-09-11
CN101903385A (zh)	2010-12-01
AR069814A1 (es)	2010-02-17
CN101903385B (zh)	2013-11-06
BRPI0820779B8 (pt)	2021-05-25
PT2235012E (pt)	2013-08-28
UA101963C2 (en)	2013-05-27
CA2709650C (en)	2016-06-07
BRPI0820779B1 (pt)	2020-02-04
JP2011506566A (ja)	2011-03-03
RU2489430C2 (ru)	2013-08-10
EP2235012A2 (en)	2010-10-06
SI2235012T1 (sl)	2013-11-29
ES2430210T3 (es)	2013-11-19
HK1149003A1 (en)	2011-09-23
HRP20130918T1 (hr)	2013-11-08
JP5498396B2 (ja)	2014-05-21
TW200938197A (en)	2009-09-16
CY1114427T1 (el)	2016-08-31
US8431580B2 (en)	2013-04-30
US20110039817A1 (en)	2011-02-17
AU2008341678A1 (en)	2009-07-02
PL2235012T3 (pl)	2013-12-31
IL206413A0 (en)	2010-12-30
EP2235012B1 (en)	2013-07-17
KR20100096184A (ko)	2010-09-01
CL2008003811A1 (es)	2009-05-22
AU2008341678B2 (en)	2013-03-21

Publication	Publication Date	Title
FR24C1047I2 (fr)	2025-10-10	Derive de 4-pyrimidinesulfamide
BRPI0813707A2 (pt)	2014-12-30	Derivados de pirimidinil-piridazinona
BRPI0820112A2 (pt)	2015-05-05	Derivados de isoxazol-piridina
BRPI0809992A2 (pt)	2014-10-14	Derivados de pirrolopirimidina
BRPI0820113A2 (pt)	2015-05-05	Derivados de isoxazolo-piridazina
ES2465673T9 (es)	2014-11-14	Derivados de pirimidina
BRPI0907435A2 (pt)	2015-07-14	Derivados de 5-flúor pirimidina
BRPI0812155A2 (pt)	2019-09-24	derivados de espiroindolinona
BRPI0817935A2 (pt)	2015-04-07	Derivados de biarila
DK2209786T3 (da)	2013-06-03	Pyrimidinsubstituerede purinderivater
BRPI0914544A2 (pt)	2015-12-15	derivados de pirimidona substituídos
BRPI0814236A2 (pt)	2015-01-06	Derivados de quinazolinamida
BRPI0813836A2 (pt)	2015-01-06	Derivados pirazólicos
BRPI0812518A2 (pt)	2015-03-31	Derivados de indazolamida
BRPI0820649A2 (pt)	2015-06-16	Derivados de isoxazalo-pirazina
BRPI0812247A2 (pt)	2015-06-16	Derivados de piridazinona
BRPI0810202A2 (pt)	2014-10-21	Derivados de piridina
BRPI0915064A2 (pt)	2015-10-27	derivados de qunoxalinadiona
BRPI0913832A2 (pt)	2015-10-20	derivados de pirrolopiridinilpirimidin-2-ilamina
DK2152370T3 (da)	2011-08-15	Aryletherpyridazinonderivater
BRPI0820779A2 (pt)	2015-06-16	Derivados de 4-amino-pirimidina
BRPI0821743A2 (pt)	2015-09-22	derivados de piridazinona
BRPI0920496A2 (pt)	2019-09-24	derivados substituídos de pirimidina etriazina
DK2142533T3 (da)	2011-12-12	Imidazolidinonderivater
ATE545635T1 (de)	2012-03-15	Substituierte n-oxidpyrazinderivate

Legal Events

Date	Code	Title	Description
2017-10-24	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-05-28	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-07-16	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2019-11-19	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2020-02-04	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 04/02/2020, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/12/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF
2025-04-01	B25D	Requested change of name of applicant approved	Owner name: PALAU PHARMA, S.A.U. (ES)
2025-04-15	B25D	Requested change of name of applicant approved	Owner name: PALAU PHARMA, S.L.U. (ES)